MGK
The arbitrator’s decision is not dependent upon
The FDA lifting the hold. However, his decision
Is highly influenced by the damages caused by
CRO non performance. Once the FDA lifts hold
It validates the safety and efficacy of Leronlimab.
Thereafter, the damages are tallied. I don’t believe
CYDY will formally settle until hold is lifted in order
To precisely measure damages.
IMO